Patents by Inventor Wanda Seyton

Wanda Seyton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibrin gel for controlled release of PDGF and uses thereof
    Patent number: 9012393
    Abstract: The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: April 21, 2015
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Isabelle Catelas, Joseph Dwyer, Wanda Seyton, Shane Donovan, Sam L. Helgerson
  • Fibrin gel for controlled release of PDGF and uses thereof
    Patent number: 8377864
    Abstract: The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: February 19, 2013
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Isabelle Catelas, Joseph Dwyer, Wanda Seyton, Shane Donovan, Sam L. Helgerson
  • BIOMATRICES TO ATTRACT AND RETAIN REGENERATIVE AND REPARATIVE CELLS
    Publication number: 20110200577
    Abstract: The invention relates to a pharmaceutical composition which comprises a fibrin clot and a cytokine and methods of delivering the composition to a site of disease or injury in vivo to attract and retain regenerative or reparative stem or myeloid cells and their differentiated progeny.
    Type: Application
    Filed: January 10, 2011
    Publication date: August 18, 2011
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Stephen L. Smith, Loredana Campo, Jennifer Campbell, Shiri Uriel Wallach, Wanda Seyton, Shane Donovan
  • FIBRIN GEL FOR CONTROLLED RELEASE OF PDGF AND USES THEREOF
    Publication number: 20090075881
    Abstract: The present invention relates, in general, to fibrin sealants, which contain platelet derived growth factor (PDGF) for controlled release in situ for therapeutic applications, including musculoskeletal disorders, soft tissue disorders and vascular diseases.
    Type: Application
    Filed: June 19, 2008
    Publication date: March 19, 2009
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Isabelle Catelas, Joseph Dwyer, Wanda Seyton, Shane Donovan, Sam L. Helgerson